CC
MRK icon

Centiva Capital’s Merck MRK Stock Holding History

Centiva Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Sell
100,000
-100,000
-50% -$11.7M 0.11% 146
2026
Q1 		$24.1M Hold
200,000
– – 0.18% 95
2025
Q4 		$21.1M Buy
200,000
+100,000
+100% +$9.39M 0.17% 95
2025
Q3 		$8.39M Buy
+100,000
New +$8.24M 0.08% 171
2024
Q4 		– Sell
-9,900
Closed -$1.12M – 2140
2024
Q3 		$1.12M Sell
9,900
-5,100
-34% -$606K 0.02% 780
2024
Q2 		$1.86M Buy
15,000
+5,000
+50% +$644K 0.03% 460
2024
Q1 		$1.32M Buy
10,000
+5,600
+127% +$690K 0.03% 520
2023
Q4 		$480K Sell
4,400
-2,600
-37% -$270K 0.01% 982
2023
Q3 		$721K Sell
7,000
-3,000
-30% -$323K 0.02% 790
2023
Q2 		$1.15M Sell
10,000
-10,000
-50% -$1.14M 0.03% 532
2023
Q1 		$2.13M Buy
20,000
+19,900
+19,900% +$2.15M 0.05% 384
2022
Q4 		$11.1K Sell
100
-10,000
-99% -$1.02M ﹤0.01% 1296
2022
Q3 		$870K Hold
10,100
– – 0.02% 672
2022
Q2 		$921K Sell
10,100
-900
-8% -$79.8K 0.02% 660
2022
Q1 		$903K Buy
11,000
+3,500
+47% +$276K 0.02% 751
2021
Q4 		$575K Buy
+7,500
New +$597K 0.01% 750
2020
Q3 		– Sell
-6,078
Closed -$449K – 817
2020
Q2 		$449K Hold
6,078
– – 0.03% 318
2020
Q1 		$446K Buy
+6,078
New +$478K 0.02% 331
2019
Q2 		– Sell
-24,628
Closed -$1.95M – 487
2019
Q1 		$1.95M Sell
24,628
-38,566
-61% -$2.88M 0.13% 111
2018
Q4 		$4.61M Buy
63,194
+29,553
+88% +$2.09M 0.36% 48
2018
Q3 		$2.28M Buy
33,641
+2,306
+7% +$147K 0.2% 78
2018
Q2 		$1.81M Buy
+31,335
New +$1.77M 0.38% 26

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centiva Capital's MRK Position: Q2 2026 in Review

Centiva Capital increased its Merck (MRK) stake by 80% in Q2 2026, buying an estimated $281K and bringing the position to 5,405 shares worth $695K. The position accounts for 0.01% of the portfolio, ranked #762.

Centiva Capital first reported a position in MRK in Q3 2019 and has held it in 23 quarters since. The position peaked at $13.9M in Q1 2023. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Centiva Capital held 5,405 shares of Merck worth $695K as of Q2 2026.
  • Centiva Capital bought 2,397 Merck shares in Q2 2026, an estimated $281K.
  • Merck made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #762 holding.
  • Centiva Capital first reported a position in Merck in Q3 2019 and has held it in 23 quarters since.
  • Centiva Capital's Merck position peaked at $13.9M in Q1 2023.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.